|
Deborah A Dillon, M.D.
Assistant Professor of Pathology
|
|
Academic Activities:
|
Office
75 Francis Street
TH-6-613 Thorn Building
Boston,MA
02115
Email1:
ddillon@partners.org
|
Education and Training:
Medical School
-
:
Yale University School of Medicine
M.D
|
Internship/Residency
07/1992
-
06/1995
:
Yale-New Haven Hospital
|
Fellowship
07/1995
-
06/1998
:
Yale-New Haven Hospital
|
Clinical Specialties:
Research Interests:
Publication:
- Dillon, D.A., D'Aquila, T., Reynolds A.B., Fearon, E.R., and Rimm, D.L. The expression of p120ctn protein in breast cancer is independent of [alpha] and [beta]-catenin and E-cadherin. Am J Path 1998;152:75-82.
- Dillon, D.A., Johnson, C.C., Topazian, M.D., Tallini, G., Rimm, D.L. and Costa, J.C. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms. Cancer J 2000;6:299-306.
- Dillon DA, Hipolito E, Zheng K, Rimm DL and Costa JC. p53 mutations as tumor markers in fine-needle aspirates of palpable breast masses. Acta Cytol 2002;46:841-847.
- Dillon DA. Molecular markers in the diagnosis and staging of breast cancer. Semin Radiat Oncol 2002;12:305-318.
- Dillon DA, Zheng K, Negin B and Costa JC. "Detection of Ki-ras and p53 mutations by laser-capture microdissection/PCR/SSCP" in Laser Capture Microdissection: Methods and Protocols, Murray GI and Curran S, eds. The Humana Press, Inc, Totowa, NJ (2004).
|
| < | Tuesday, February 09, 2010 | > |
|
|